Turpeinen AK, Kuikka JT, Vanninen E, and et al
Your weight loss journey is guided every step of the way by a medical team that listens and cares for you
We complete and submit it for you
The question behind the question is usually: "How much longer will I be able to get compounded semaglutide at this price?" The pattern we see: patients conflate three separate timelines: Patent expiration (2031-2033 for the formulations that matter) FDA shortage list removal (expected late 2026 to Q1 2027) Generic market entry (2027 for oral, 2031-2032 for injectable, assuming no patent challenges) The timeline that affects current compounded access is number 2, not number 1
Understanding the mechanism, safety profile, and monitoring requirements of this combination is essential before starting treatment
Both medications stay in your system for several days, so youll maintain benefits and shouldnt lose your progress during the transition